Glucophage XR

Glucophage XR Indications/Uses

metformin

Manufacturer:

PT. Merck Tbk
Full Prescribing Info
Indications/Uses
Reduction in the risk or delay of the onset of type 2 diabetes mellitus in adult, overweight patients with IGT* (Prediabetes) and/or IFG*, and/or increased HbA1C who are: at high risk for developing overt type 2 diabetes mellitus and still progressing towards type 2 diabetes mellitus despite implementation of intensive lifestyle change for 3 to 6 months.
Treatment with Glucophage XR must be based on a risk score incorporating appropriate measures of glycaemic control and including evidence of high cardiovascular risk.
Lifestyle modifications should be continued when Metformin is initiated, unless the patient is unable to do so because of medical reasons.
*IGT: Impaired Glucose Tolerance; IFG: Impaired Fasting Glucose
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Glucophage XR may be used as monotherapy or in combination with other oral antidiabetic agents, or with Insulin.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in